RegentAtlantic Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $12.5M | Sell |
55,645
-1,644
| -3% | -$398K | 0.38% | 39 |
|
|
2022
Q2 | $13.9M | Buy |
57,289
+1,317
| +2% | +$323K | 0.46% | 32 |
|
|
2022
Q1 | $13.5M | Buy |
55,972
+837
| +2% | +$192K | 0.38% | 46 |
|
|
2021
Q4 | $12.4M | Sell |
55,135
-846
| -2% | -$179K | 0.35% | 49 |
|
|
2021
Q3 | $11.9M | Sell |
55,981
-2,245
| -4% | -$517K | 0.36% | 47 |
|
|
2021
Q2 | $14.2M | Buy |
58,226
+2,724
| +5% | +$670K | 0.44% | 43 |
|
|
2021
Q1 | $13.8M | Buy |
55,502
+1,935
| +4% | +$462K | 0.47% | 40 |
|
|
2020
Q4 | $12.3M | Buy |
53,567
+205
| +0.4% | +$47.3K | 0.49% | 35 |
|
|
2020
Q3 | $13.6M | Sell |
53,362
-278
| -0.5% | -$68.9K | 0.61% | 31 |
|
|
2020
Q2 | $12.7M | Buy |
53,640
+4,725
| +10% | +$1.08M | 0.7% | 29 |
|
|
2020
Q1 | $9.92M | Sell |
48,915
-1,656
| -3% | -$362K | 0.77% | 28 |
|
|
2019
Q4 | $12.2M | Sell |
50,571
-1,836
| -4% | -$405K | 0.74% | 30 |
|
|
2019
Q3 | $10.1M | Sell |
52,407
-2,116
| -4% | -$406K | 0.67% | 36 |
|
|
2019
Q2 | $10M | Sell |
54,523
-1,255
| -2% | -$225K | 0.68% | 32 |
|
|
2019
Q1 | $10.6M | Sell |
55,778
-761
| -1% | -$145K | 0.74% | 30 |
|
|
2018
Q4 | $11M | Sell |
56,539
-2,536
| -4% | -$495K | 0.93% | 22 |
|
|
2018
Q3 | $12.2M | Sell |
59,075
-9,864
| -14% | -$1.94M | 0.94% | 27 |
|
|
2018
Q2 | $12.7M | Sell |
68,939
-6,877
| -9% | -$1.22M | 1.1% | 19 |
|
|
2018
Q1 | $12.9M | Sell |
75,816
-1,181
| -2% | -$217K | 1.08% | 19 |
|
|
2017
Q4 | $13.4M | Buy |
76,997
+3,620
| +5% | +$641K | 1.1% | 17 |
|
|
2017
Q3 | $13.7M | Buy |
73,377
+1,166
| +2% | +$207K | 1.18% | 16 |
|
|
2017
Q2 | $12.4M | Buy |
72,211
+597
| +0.8% | +$97.1K | 1.13% | 19 |
|
|
2017
Q1 | $11.8M | Buy |
71,614
+1,301
| +2% | +$216K | 1.09% | 22 |
|
|
2016
Q4 | $10.3M | Buy |
70,313
+3,047
| +5% | +$459K | 1% | 25 |
|
|
2016
Q3 | $11.2M | Buy |
67,266
+2,195
| +3% | +$371K | 1.16% | 18 |
|
|
2016
Q2 | $9.9M | Buy |
65,071
+306
| +0.5% | +$47.6K | 0.96% | 23 |
|
|
2016
Q1 | $9.71M | Sell |
64,765
-2,426
| -4% | -$360K | 1.07% | 20 |
|
|
2015
Q4 | $10.9M | Buy |
67,191
+10,014
| +18% | +$1.57M | 1.17% | 21 |
|
|
2015
Q3 | $7.91M | Buy |
57,177
+685
| +1% | +$108K | 0.76% | 34 |
|
|
2015
Q2 | $8.67M | Buy |
56,492
+2,819
| +5% | +$452K | 0.77% | 31 |
|
|
2015
Q1 | $8.58M | Buy |
53,673
+850
| +2% | +$134K | 0.75% | 32 |
|
|
2014
Q4 | $8.41M | Sell |
52,823
-3,790
| -7% | -$591K | 0.71% | 36 |
|
|
2014
Q3 | $7.95M | Sell |
56,613
-1,575
| -3% | -$206K | 0.74% | 33 |
|
|
2014
Q2 | $6.89M | Buy |
58,188
+3,029
| +5% | +$351K | 0.64% | 39 |
|
|
2014
Q1 | $6.8M | Sell |
55,159
-58
| -0.1% | -$7.03K | 0.66% | 40 |
|
|
2013
Q4 | $6.3M | Sell |
55,217
-175
| -0.3% | -$19.9K | 0.61% | 42 |
|
|
2013
Q3 | $6.2M | Sell |
55,392
-2,685
| -5% | -$291K | 0.68% | 38 |
|
|
2013
Q2 | $5.73M | Buy |
+58,077
| New | +$6.03M | 0.68% | 37 |
|
Other funds holding AMGN
RegentAtlantic Capital's AMGN Position: Q3 2022 in Review
RegentAtlantic Capital reduced its Amgen (AMGN) stake by 2.9% in Q3 2022, selling an estimated $398K and leaving 55,645 shares worth $12.5M. The position accounts for 0.38% of the portfolio, ranked #39.
RegentAtlantic Capital first reported a position in AMGN in Q2 2013 and has held it in 38 quarters since. The position peaked at $14.2M in Q2 2021. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- RegentAtlantic Capital held 55,645 shares of Amgen worth $12.5M as of Q3 2022.
- RegentAtlantic Capital sold 1,644 Amgen shares in Q3 2022, an estimated $398K.
- Amgen made up 0.38% of RegentAtlantic Capital's portfolio in Q3 2022, its #39 holding.
- RegentAtlantic Capital first reported a position in Amgen in Q2 2013 and has held it in 38 quarters since.
- RegentAtlantic Capital's Amgen position peaked at $14.2M in Q2 2021.
- 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.